Status:
UNKNOWN
Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation for Small Renal Masses
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Small Renal Masses (SRM)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The execution of this study is pertinent to evaluating SBRT's short- and long-term efficacy and safety in the treatment of SRMs. This study will be the first to compare RFA and SBRT in the treatment o...
Eligibility Criteria
Inclusion
- Patients ≥18 years of age and capable of providing informed consent
- Patients scheduled for treatment of their SRM using SBRT or RFA
- Patients who received a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
- Patients who are willing to have a biopsy 12 months post-procedure
- Patients with renal tumor(s) ≤ 4.0 cm
Exclusion
- Patients with large renal tumor(s)\>4.0 cm
- Patients who are unable to have a general anesthetic
- Patients who did not receive a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
- Patients who are unable to comply with post-operative and/or follow-up protocol/phase of study
- Evidence of metastatic disease
- Uncorrectable bleeding diathesis
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03811665
Start Date
October 1 2019
End Date
December 30 2022
Last Update
December 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster Institute of Urology - St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6